Vivos (RDGL) Gross Profit Growth (1y) (2011 - 2025)
Vivos (RDGL) Gross Profit Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 15.59% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 17.10% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 12.38% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.54% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 20.50% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.82% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 4.20% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.95% |
| 10 | Vivos | 24.08 Mn | 22.53 Mn | -3,105.00 | 41.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.25% |
| Sep 30, 2025 | -1,285.48% |
| Jun 30, 2025 | -1,377.68% |
| Mar 31, 2025 | -505.53% |
| Dec 31, 2024 | 41.28% |
| Sep 30, 2024 | -84.56% |
| Jun 30, 2024 | 208.80% |
| Mar 31, 2024 | 2.34% |
| Dec 31, 2023 | -112.92% |
| Sep 30, 2023 | 207.12% |
| Jun 30, 2023 | -129.47% |
| Mar 31, 2023 | -115.36% |
| Dec 31, 2022 | 29.55% |
| Sep 30, 2022 | -173.53% |
| Dec 31, 2015 | 100.01% |
| Sep 30, 2015 | 4,648.30% |
| Jun 30, 2015 | -100.87% |
| Mar 31, 2015 | -15.50% |
| Dec 31, 2014 | -2,724.85% |
| Sep 30, 2014 | -101.71% |